NCT04371029

Brief Summary

Most patients in intensive care units (ICUs) experience severe sleep disruption. Sleep disruption and sleep alteration may have an influence on the ability to breathe spontaneously. But, the cause of altered sleep remains unknown. Previous studies have shown that decreasing nocturnal respiratory muscle activity through mechanical ventilation might improve sleep quality. Nocturnal respiratory muscle activity may be one of the potential factor which contribute to alter sleep in the ICU. Therefore, the aim of this study is to analyse the presence of NIM activation during the night and it's consequence in an ICU population with the same pathology (COVID 19 ARDS).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 28, 2020

Completed
Same day until next milestone

Study Start

First participant enrolled

April 28, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 1, 2020

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 9, 2020

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 9, 2020

Completed
Last Updated

June 7, 2021

Status Verified

June 1, 2021

Enrollment Period

4 months

First QC Date

April 28, 2020

Last Update Submit

June 4, 2021

Conditions

Keywords

Neck inspiratory muscle (=NIM)SleepIntensive care unitARDS

Outcome Measures

Primary Outcomes (1)

  • Proportion of patients with altered spleep

    Comparison between patients with NIM activation during the night and patients without NIM activation during the night, in patients COVID 19 ARDS with altered spleep. A Polysomnography (PSG) will be performed the night before extubation.

    At day 10 after inclusion

Secondary Outcomes (5)

  • Sleep architecture at hospital discharge

    At day 28 after inclusion

  • Sleep monitoring during hospital stay after ICU discharge

    At day 18 after ICU discharge

  • Sleep quality

    3 months after hospiotal discharge

  • Sleep architecture at month-3

    3 months after hospital discharge

  • Cost of ICU hospitalization

    From inclusion to ICU discharge, up to 10 days after inclusion

Study Arms (1)

Experimental

EXPERIMENTAL

A Polysomnography (PSG) will be performed in all patient the night before extubation, the day prior discharge and 3 month after. Recording will consist in EEG, EOG et EMG of the chin. We will record NIM EMG. We will also performed an actimetry during hospitalization in the post ICU ward. A quality of sleep questionnaire (Pittsburgh questionnaire) will be completed by the patients during the visit at 3 month.

Other: PSG

Interventions

PSGOTHER

Polysomnography at 3 times, actimetry measure and Pittsburgh questionnaire

Experimental

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient above 18 year-old admitted to intensive care unit
  • COVID-19 assessed by PCR on nasopharyngeal swab or pulmonary sample
  • Oro-tracheal intubation for mechanical ventilation

You may not qualify if:

  • Guardianship or curatorship
  • Prisoners
  • No health insurance
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hopital Pellegrin

Bordeaux, 33000, France

Location

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 28, 2020

First Posted

May 1, 2020

Study Start

April 28, 2020

Primary Completion

September 9, 2020

Study Completion

December 9, 2020

Last Updated

June 7, 2021

Record last verified: 2021-06

Data Sharing

IPD Sharing
Will not share

Locations